Eastern 0 7 0 7 B-clinical_variable
Cooperative 8 19 8 19 I-clinical_variable
Oncology 20 28 20 28 I-clinical_variable
Group 29 34 29 34 I-clinical_variable
( 35 36 35 36 I-clinical_variable
ECOG 36 40 36 40 I-clinical_variable
) 40 41 40 41 I-clinical_variable
performance 42 53 42 53 I-clinical_variable
status 54 60 54 60 I-clinical_variable
must 61 65 61 65 O
be 66 68 66 68 O
0 69 70 69 70 B-lower_bound
or 71 73 71 73 O
1 74 75 74 75 B-upper_bound
, 75 76 75 76 O
and 77 80 77 80 O
life 81 85 81 85 B-clinical_variable
expectancy 86 96 86 96 I-clinical_variable
should 97 103 97 103 O
be 104 106 104 106 O
approximately 107 120 107 120 B-lower_bound
5 121 122 121 122 I-lower_bound
months 123 129 123 129 I-lower_bound
or 130 132 130 132 O
more 133 137 133 137 O

For 0 3 138 141 O
HCC 4 7 142 145 B-cancer
with 8 12 146 150 O
prior 13 18 151 156 O
hepatitis 19 28 157 166 B-chronic_disease
B 29 30 167 168 I-chronic_disease
and/or 31 37 169 175 I-chronic_disease
C 38 39 176 177 I-chronic_disease
infection 40 49 178 187 I-chronic_disease
, 49 50 187 188 O
HBV 51 54 189 192 B-chronic_disease
and/or 55 61 193 199 O
HCV 62 65 200 203 B-chronic_disease
viral 66 71 204 209 O
load 72 76 210 214 O
by 77 79 215 217 O
real 80 84 218 222 O
time 85 89 223 227 O
polymerase 90 100 228 238 B-treatment
chain 101 106 239 244 I-treatment
reaction 107 115 245 253 I-treatment
( 116 117 254 255 I-treatment
qPCR 117 121 255 259 I-treatment
) 121 122 259 260 I-treatment
must 123 127 261 265 O
be 128 130 266 268 O
undetectable 131 143 269 281 O
, 143 144 281 282 O
and 145 148 283 286 O
they 149 153 287 291 O
must 154 158 292 296 O
not 159 162 297 300 O
have 163 167 301 305 O
had 168 171 306 309 O
recent 172 178 310 316 B-treatment
treatment 179 188 317 326 I-treatment
within 189 195 327 333 O
12 196 198 334 336 B-upper_bound
weeks 199 204 337 342 I-upper_bound
for 205 208 343 346 O
HBV 209 212 347 350 O
or 213 215 351 353 O
HCV 216 219 354 357 O
with 220 224 358 362 O
certain 225 232 363 370 O
antiviral 233 242 371 380 B-treatment
medications 243 254 381 392 I-treatment

For 0 3 393 396 O
non 4 7 397 400 O
- 7 8 400 401 O
HCC 8 11 401 404 B-cancer
, 11 12 404 405 O
there 13 18 406 411 O
must 19 23 412 416 O
not 24 27 417 420 O
be 28 30 421 423 O
acute 31 36 424 429 O
or 37 39 430 432 O
chronic 40 47 433 440 O
active 48 54 441 447 O
hepatitis 55 64 448 457 B-chronic_disease
B 65 66 458 459 I-chronic_disease
virus 67 72 460 465 I-chronic_disease
( 73 74 466 467 I-chronic_disease
HBV 74 77 467 470 I-chronic_disease
) 77 78 470 471 I-chronic_disease
or 79 81 472 474 O
hepatitis 82 91 475 484 B-chronic_disease
C 92 93 485 486 I-chronic_disease
virus 94 99 487 492 I-chronic_disease
( 100 101 493 494 I-chronic_disease
HCV 101 104 494 497 I-chronic_disease
) 104 105 497 498 I-chronic_disease
infection 106 115 499 508 I-chronic_disease

For 0 3 509 512 O
the 4 7 513 516 O
combination 8 19 517 528 O
cohorts 20 27 529 536 O
( 28 29 537 538 O
Cohorts 29 36 538 545 O
5 37 38 546 547 O
and 39 42 548 551 O
6 43 44 552 553 O
in 45 47 554 556 O
Part 48 52 557 561 O
1 53 54 562 563 O
) 54 55 563 564 O
and 56 59 565 568 O
Part 60 64 569 573 O
2 65 66 574 575 O
, 66 67 575 576 O
subjects 68 76 577 585 O
with 77 81 586 590 O
metastatic 82 92 591 601 B-cancer
melanoma 93 101 602 610 I-cancer
or 102 104 611 613 O
NSCLC 105 110 614 619 B-cancer
do 111 113 620 622 O
not 114 117 623 626 O
need 118 122 627 631 O
to 123 125 632 634 O
have 126 130 635 639 O
received 131 139 640 648 O
prior 140 145 649 654 B-treatment
therapy 146 153 655 662 I-treatment

Liver 0 5 663 668 O
function 6 14 669 677 O
tests 15 20 678 683 O
may 21 24 684 687 O
be 25 27 688 690 O
mildly 28 34 691 697 O
abnormal 35 43 698 706 O
but 44 47 707 710 O
within 48 54 711 717 O
the 55 58 718 721 O
parameters 59 69 722 732 O
. 69 70 732 733 O
Child 71 76 734 739 B-clinical_variable
Pugh 77 81 740 744 I-clinical_variable
score 82 87 745 750 I-clinical_variable
must 88 92 751 755 O
be 93 95 756 758 O
A 96 97 759 760 O
to 98 100 761 763 O
B7 101 103 764 766 O

Liver 0 5 767 772 B-treatment
tumor 6 11 773 778 I-treatment
- 11 12 778 779 I-treatment
directed 12 20 779 787 I-treatment
therapy 21 28 788 795 I-treatment
, 28 29 795 796 O
hepatic 30 37 797 804 B-treatment
surgery 38 45 805 812 I-treatment
, 45 46 812 813 O
antibody 47 55 814 822 B-treatment
- 55 56 822 823 I-treatment
based 56 61 823 828 I-treatment
therapy 62 69 829 836 I-treatment
, 69 70 836 837 O
or 71 73 838 840 O
immunotherapy 74 87 841 854 B-treatment
must 88 92 855 859 O
not 93 96 860 863 O
have 97 101 864 868 O
been 102 106 869 873 O
performed 107 116 874 883 O
< 117 118 884 885 O
28 119 121 886 888 B-upper_bound
days 122 126 889 893 I-upper_bound
, 126 127 893 894 O
chemotherapy 128 140 895 907 B-treatment
< 141 142 908 909 O
21 143 145 910 912 B-upper_bound
days 146 150 913 917 I-upper_bound
, 150 151 917 918 O
and 152 155 919 922 O
targeted 156 164 923 931 B-treatment
small 165 170 932 937 I-treatment
molecule 171 179 938 946 I-treatment
therapy 180 187 947 954 I-treatment
or 188 190 955 957 O
hormonal 191 199 958 966 B-treatment
therapy 200 207 967 974 I-treatment
< 208 209 975 976 O
14 210 212 977 979 B-upper_bound
days 213 217 980 984 I-upper_bound
prior 218 223 985 990 I-upper_bound
to 224 226 991 993 O
enrollment 227 237 994 1004 O

Liver 0 5 1005 1010 B-cancer
tumors 6 12 1011 1017 I-cancer
must 13 17 1018 1022 O
not 18 21 1023 1026 O
be 22 24 1027 1029 O
estimated 25 34 1030 1039 O
to 35 37 1040 1042 O
invade 38 44 1043 1049 O
approximately 45 58 1050 1063 O
more 59 63 1064 1068 O
than 64 68 1069 1073 O
one 69 72 1074 1077 O
- 72 73 1077 1078 O
third 73 78 1078 1083 O
of 79 81 1084 1086 O
the 82 85 1087 1090 O
liver 86 91 1091 1096 O

Male 0 4 1097 1101 B-gender
subjects 5 13 1102 1110 I-gender
of 14 16 1111 1113 O
reproductive 17 29 1114 1126 O
potential 30 39 1127 1136 O
in 40 42 1137 1139 O
the 43 46 1140 1143 O
combination 47 58 1144 1155 O
treatment 59 68 1156 1165 O

Non 0 3 1166 1169 B-cancer
- 3 4 1169 1170 I-cancer
HCC 4 7 1170 1173 I-cancer
subjects 8 16 1174 1182 O
must 17 21 1183 1187 O
have 22 26 1188 1192 O
received 27 35 1193 1201 O
at 36 38 1202 1204 O
least 39 44 1205 1210 O
1 45 46 1211 1212 B-lower_bound
prior 47 52 1213 1218 I-lower_bound
standard 53 61 1219 1227 I-treatment
of 62 64 1228 1230 I-treatment
care 65 69 1231 1235 I-treatment
systemic 70 78 1236 1244 I-treatment
anti 79 83 1245 1249 I-treatment
- 83 84 1249 1250 I-treatment
cancer 84 90 1250 1256 I-treatment
therapy 91 98 1257 1264 I-treatment
for 99 102 1265 1268 O
their 103 108 1269 1274 O
locally 109 116 1275 1282 O
advanced 117 125 1283 1291 B-cancer
or 126 128 1292 1294 O
metastatic 129 139 1295 1305 B-cancer
disease 140 147 1306 1313 I-cancer

Subjects 0 8 1314 1322 O
must 9 13 1323 1327 O
be 14 16 1328 1330 O
age 17 20 1331 1334 B-age
â‰¥ 21 22 1335 1336 O
18 23 25 1337 1339 B-lower_bound
years 26 31 1340 1345 I-lower_bound
at 32 34 1346 1348 O
the 35 38 1349 1352 O
time 39 43 1353 1357 O
of 44 46 1358 1360 O
informed 47 55 1361 1369 O
consent 56 63 1370 1377 O

Subjects 0 8 1378 1386 O
must 9 13 1387 1391 O
either 14 20 1392 1398 O
have 21 25 1399 1403 O
no 26 28 1404 1406 O
central 29 36 1407 1414 B-cancer
nervous 37 44 1415 1422 I-cancer
system 45 51 1423 1429 I-cancer
( 52 53 1430 1431 I-cancer
CNS 53 56 1431 1434 I-cancer
) 56 57 1434 1435 I-cancer
metastasis 58 68 1436 1446 I-cancer
, 68 69 1446 1447 O
or 70 72 1448 1450 O
carcinomatous 73 86 1451 1464 B-cancer
meningitis 87 97 1465 1475 I-cancer
, 97 98 1475 1476 O
or 99 101 1477 1479 O
if 102 104 1480 1482 O
CNS 105 108 1483 1486 B-cancer
metastasis 109 119 1487 1497 I-cancer
is 120 122 1498 1500 O
present 123 130 1501 1508 O
, 130 131 1508 1509 O
must 132 136 1510 1514 O
have 137 141 1515 1519 O
stable 142 148 1520 1526 O
treated 149 156 1527 1534 O
cerebral 157 165 1535 1543 B-cancer
metastases 166 176 1544 1554 I-cancer
from 177 181 1555 1559 O
BC 182 184 1560 1562 O
, 184 185 1562 1563 O
NSCLC 186 191 1564 1569 B-cancer
, 191 192 1569 1570 O
RCC 193 196 1571 1574 B-cancer
, 196 197 1574 1575 O
CRC 198 201 1576 1579 O
, 201 202 1579 1580 O
GEC 203 206 1581 1584 O
, 206 207 1584 1585 O
or 208 210 1586 1588 O
melanoma 211 219 1589 1597 B-cancer

Subjects 0 8 1598 1606 O
must 9 13 1607 1611 O
have 14 18 1612 1616 O
measurable 19 29 1617 1627 O
liver 30 35 1628 1633 B-cancer
tumors 36 42 1634 1640 I-cancer
and 43 46 1641 1644 O
lesions 47 54 1645 1652 O
that 55 59 1653 1657 O
are 60 63 1658 1661 O
suitable 64 72 1662 1670 O
for 73 76 1671 1674 O
injection 77 86 1675 1684 O

Subjects 0 8 1685 1693 O
must 9 13 1694 1698 O
not 14 17 1699 1702 O
be 18 20 1703 1705 O
candidates 21 31 1706 1716 O
for 32 35 1717 1720 O
hepatic 36 43 1721 1728 B-treatment
surgery 44 51 1729 1736 I-treatment
or 52 54 1737 1739 O
locoregional 55 67 1740 1752 B-treatment
therapy 68 75 1753 1760 I-treatment
of 76 78 1761 1763 O
liver 79 84 1764 1769 B-cancer
tumors 85 91 1770 1776 I-cancer
with 92 96 1777 1781 O
curative 97 105 1782 1790 O
intent 106 112 1791 1797 O
or 113 115 1798 1800 O
planned 116 123 1801 1808 O
immediate 124 133 1809 1818 B-treatment
systemic 134 142 1819 1827 I-treatment
anti 143 147 1828 1832 I-treatment
- 147 148 1832 1833 I-treatment
cancer 148 154 1833 1839 I-treatment
therapy 155 162 1840 1847 I-treatment

Subjects 0 8 1848 1856 O
must 9 13 1857 1861 O
not 14 17 1862 1865 O
have 18 22 1866 1870 O
symptomatic 23 34 1871 1882 B-chronic_disease
auto 35 39 1883 1887 I-chronic_disease
- 39 40 1887 1888 I-chronic_disease
immune 40 46 1888 1894 I-chronic_disease
disease 47 54 1895 1902 I-chronic_disease
or 55 57 1903 1905 O
be 58 60 1906 1908 O
immunosuppressed 61 77 1909 1925 O

Subjects 0 8 1926 1934 O
must 9 13 1935 1939 O
not 14 17 1940 1943 O
: 17 18 1943 1944 O
have 19 23 1945 1949 O
active 24 30 1950 1956 O
herpetic 31 39 1957 1965 B-chronic_disease
skin 40 44 1966 1970 I-chronic_disease
lesions 45 52 1971 1978 I-chronic_disease
or 53 55 1979 1981 O
prior 56 61 1982 1987 O
complications 62 75 1988 2001 O
of 76 78 2002 2004 O
herpetic 79 87 2005 2013 B-chronic_disease
infection 88 97 2014 2023 I-chronic_disease
( 98 99 2024 2025 O
eg 99 101 2025 2027 O
, 101 102 2027 2028 O
herpetic 103 111 2029 2037 B-chronic_disease
keratitis 112 121 2038 2047 I-chronic_disease
or 122 124 2048 2050 O
encephalitis 125 137 2051 2063 B-chronic_disease
) 137 138 2063 2064 O

There 0 5 2065 2070 O
should 6 12 2071 2077 O
be 13 15 2078 2080 O
no 16 18 2081 2083 O
macroscopic 19 30 2084 2095 B-treatment
intravascular 31 44 2096 2109 I-treatment
invasion 45 53 2110 2118 I-treatment
of 54 56 2119 2121 O
tumors 57 63 2122 2128 B-cancer
into 64 68 2129 2133 O
the 69 72 2134 2137 O
main 73 77 2138 2142 O
portal 78 84 2143 2149 O
vein 85 89 2150 2154 O
, 89 90 2154 2155 O
hepatic 91 98 2156 2163 O
vein 99 103 2164 2168 O
, 103 104 2168 2169 O
or 105 107 2170 2172 O
vena 108 112 2173 2177 O
cava 113 117 2178 2182 O

They 0 4 2183 2187 O
must 5 9 2188 2192 O
have 10 14 2193 2197 O
histologically 15 29 2198 2212 O
or 30 32 2213 2215 O
cytologically 33 46 2216 2229 O
confirmed 47 56 2230 2239 O
BC 57 59 2240 2242 B-cancer
, 59 60 2242 2243 O
CRC 61 64 2244 2247 B-cancer
, 64 65 2247 2248 O
GEC 66 69 2249 2252 B-cancer
, 69 70 2252 2253 O
melanoma 71 79 2254 2262 B-cancer
, 79 80 2262 2263 O
NSCLC 81 86 2264 2269 B-cancer
, 86 87 2269 2270 O
or 88 90 2271 2273 O
RCC 91 94 2274 2277 B-cancer
with 95 99 2278 2282 O
liver 100 105 2283 2288 B-cancer
metastases 106 116 2289 2299 I-cancer
or 117 119 2300 2302 O
HCC 120 123 2303 2306 B-cancer

They 0 4 2307 2311 O
must 5 9 2312 2316 O
not 10 13 2317 2320 O
require 14 21 2321 2328 O
concomitant 22 33 2329 2340 B-treatment
treatment 34 43 2341 2350 I-treatment
with 44 48 2351 2355 O
warfarin 49 57 2356 2364 B-treatment

expected 0 8 2365 2373 O
other 9 14 2374 2379 O
cancer 15 21 2380 2386 B-treatment
therapy 22 29 2387 2394 I-treatment
while 30 35 2395 2400 O
on 36 38 2401 2403 O
study 39 44 2404 2409 O
with 45 49 2410 2414 O
the 50 53 2415 2418 O
exception 54 63 2419 2428 O
of 64 66 2429 2431 O
local 67 72 2432 2437 O
radiation 73 82 2438 2447 O
to 83 85 2448 2450 O
the 86 89 2451 2454 O
site 90 94 2455 2459 O
of 95 97 2460 2462 O
bone 98 102 2463 2467 O
or 103 105 2468 2470 O
other 106 111 2471 2476 O
metastasis 112 122 2477 2487 B-cancer
for 123 126 2488 2491 O
palliative 127 137 2492 2502 B-treatment
treatment 138 147 2503 2512 I-treatment

fibrolamellar 0 13 2513 2526 B-cancer
and 14 17 2527 2530 I-cancer
mixed 18 23 2531 2536 I-cancer
hepatocellular 24 38 2537 2551 I-cancer
/ 38 39 2551 2552 I-cancer
cholangiocarcinoma 39 57 2552 2570 I-cancer
subtypes 58 66 2571 2579 O

have 0 4 2580 2584 O
previous 5 13 2585 2593 B-treatment
therapy 14 21 2594 2601 I-treatment
with 22 26 2602 2606 I-treatment
talimogene 27 37 2607 2617 I-treatment
laherparepvec 38 51 2618 2631 I-treatment
, 51 52 2631 2632 O
oncolyic 53 61 2633 2641 B-treatment
viruses 62 69 2642 2649 I-treatment
, 69 70 2649 2650 O
or 71 73 2651 2653 O
tumor 74 79 2654 2659 B-treatment
vaccine 80 87 2660 2667 I-treatment

have 0 4 2668 2672 O
received 5 13 2673 2681 O
live 14 18 2682 2686 B-treatment
- 18 19 2686 2687 I-treatment
virus 19 24 2687 2692 I-treatment
vaccination 25 36 2693 2704 I-treatment
within 37 43 2705 2711 O
30 44 46 2712 2714 B-upper_bound
days 47 51 2715 2719 I-upper_bound
of 52 54 2720 2722 O
planned 55 62 2723 2730 O
treatment 63 72 2731 2740 O
start 73 78 2741 2746 O

history 0 7 2747 2754 O
of 8 10 2755 2757 O
solid 11 16 2758 2763 B-treatment
organ 17 22 2764 2769 I-treatment
transplantation 23 38 2770 2785 I-treatment

immunotherapy 0 13 2786 2799 B-treatment
in 14 16 2800 2802 O
the 17 20 2803 2806 O
combination 21 32 2807 2818 O
cohorts 33 40 2819 2826 O
( 41 42 2827 2828 O
Cohorts 42 49 2828 2835 O
5 50 51 2836 2837 O
and 52 55 2838 2841 O
6 56 57 2842 2843 O
in 58 60 2844 2846 O
Part 61 65 2847 2851 O
1 66 67 2852 2853 O
and 68 71 2854 2857 O
all 72 75 2858 2861 O
subjects 76 84 2862 2870 O
in 85 87 2871 2873 O
Part 88 92 2874 2878 O
2 93 94 2879 2880 O
) 94 95 2880 2881 O

must 0 4 2882 2886 O
be 5 7 2887 2889 O
willing 8 15 2890 2897 B-contraception_consent
to 16 18 2898 2900 I-contraception_consent
use 19 22 2901 2904 I-contraception_consent
acceptable 23 33 2905 2915 I-contraception_consent
methods 34 41 2916 2923 I-contraception_consent
of 42 44 2924 2926 I-contraception_consent
effective 45 54 2927 2936 I-contraception_consent
contraception 55 68 2937 2950 I-contraception_consent
during 69 75 2951 2957 O
treatment 76 85 2958 2967 O
and 86 89 2968 2971 O
through 90 97 2972 2979 O
4 98 99 2980 2981 B-upper_bound
months 100 106 2982 2988 I-upper_bound
after 107 112 2989 2994 O
the 113 116 2995 2998 O
last 117 121 2999 3003 O
dose 122 126 3004 3008 O
of 127 129 3009 3011 O
pembrolizumab 130 143 3012 3025 B-treatment

toxic 0 5 3026 3031 O
effects 6 13 3032 3039 O
of 14 16 3040 3042 O
the 17 20 3043 3046 O
most 21 25 3047 3051 O
recent 26 32 3052 3058 O
prior 33 38 3059 3064 B-treatment
chemotherapy 39 51 3065 3077 I-treatment
not 52 55 3078 3081 O
resolved 56 64 3082 3090 O
to 65 67 3091 3093 O
grade 68 73 3094 3099 B-upper_bound
1 74 75 3100 3101 I-upper_bound
or 76 78 3102 3104 O
less 79 83 3105 3109 O
( 84 85 3110 3111 O
except 85 91 3111 3117 O
alopecia 92 100 3118 3126 B-chronic_disease
) 100 101 3126 3127 O

